Provides temperature-controlled transport, storage and cryopreservation services for life sciences customers, and sells cryogenic freezers and transport systems to biopharmaceutical companies, laboratories and research institutions.
10-K for FY2025, filed Mar 5, 2026BioLogistics Solutions. Our BioLogistics solutions provide highly specific, temperature-controlled transportation services for CGT and…View ↗
BioStorage Solutions. Our BioStorage solutions provide temperature-controlled biostorage and value-added services that support life…View ↗
Cryopreservation Services (IntegriCell). Our Cryopreservation Services, offered under our IntegriCell platform, providing standardized…View ↗
Cryogenic Systems Manufacturing. We are a leading global manufacturer of cryogenic systems for the storage and transportation of biological…View ↗
MVE, with more than 65 years of experience designing and manufacturing cryogenic storage and transport systems, offers a broad portfolio of…View ↗
Customers pay for storage and logistics support as those services are performed and for cryogenic equipment when it is delivered; invoices are generally due within 15 to 60 days. Shipper-use fees are earned when the shipper reaches the end user.
10-K for FY2025, filed Mar 5, 2026For arrangements under which the Company provides biological specimen storage services and logistics support and management to the…View ↗
Pursuant to the Company’s contracts with its customers, amounts billed for services or products delivered by the Company are generally due…View ↗
The Company recognizes revenue for the use of the Cryoport Express® Shippers at the time of the delivery of the Cryoport Express® Shipper…View ↗
The Company also provides vacuum insulated aluminum dewars and cryogenic freezers systems to its customers. Revenue is recognized when the…View ↗
10-K for FY2025, filed Mar 5, 2026
FY2025 revenue by product or service ↗$176.2M
10-K for FY2025, filed Mar 5, 2026
$176.2M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
BioLogistics Solutions
Sold outright
10-K for FY2025, filed Mar 5, 2026 |
44%
FY2022: 53%
|
BioLogistics Solutions, FY2025
$78.1M Sources
|
Sold outright |
|
BioStorage/BioServices
Recurring
10-K for FY2025, filed Mar 5, 2026 |
10%
FY2022: 3.8%
|
BioStorage/BioServices, FY2025
$18.4M Sources
|
Recurring |
|
Product
Sold outright
10-K for FY2025, filed Mar 5, 2026 |
45%
FY2022: 44%
|
Product, FY2025
$79.7M Sources
|
Sold outright |
Biotechnology and pharmaceutical companies, research organizations and clinics buy its services directly; cryogenic systems go to life sciences customers through direct sales or distributors.
10-K for FY2025, filed Mar 5, 2026
10-K for FY2025, filed Mar 5, 2026
The Company has revenue from foreign customers primarily in the United Kingdom, France, Germany and China. During the years ended December…View ↗
Yes. It kept 44 cents of every revenue dollar as net income in FY2025, but spent more cash than it brought in: free cash flow was −$25M.
10-Q for Q3 FY2026, filed Nov 5, 2026
−$10.9MView ↗
10-Q for Q3 FY2026, filed Nov 5, 2026
Open tableView ↗
Shrinking. Revenue fell 21% in 4 years, from $222.6M in FY2021 to $176.2M in FY2025, about 6% a year.
CRYOPDP divestiture
The earlier report included CRYOPDP's courier operations in its global logistics offering; the latest report says Cryoport sold that business and describes its continuing operations without it.
10-K for FY2022, filed Feb 28, 2023 10-K for FY2025, filed Mar 5, 2026In October 2020, we acquired CRYOPDP, a leading global provider of innovative temperature-controlled logistics solutions for high value…View ↗
During the second quarter of fiscal year 2025, we completed the divestiture of our specialty courier CRYOPDP business to designated…View ↗
Cryopreservation service rollout
The earlier report described Cell Matters as the basis for a planned cryopreservation platform; the latest says IntegriCell services are offered and biopharma companies are being onboarded.
10-K for FY2022, filed Feb 28, 2023 10-K for FY2025, filed Mar 5, 2026In July 2022, we also acquired Cell Matters based in Liège, Belgium, a company with cryobiology expertise, providing cryo-process…View ↗
Competes with World Courier, UPS Healthcare, Quick, Biocair, American Red Cross, Gift of Life Biologics, Azenta Life Sciences, Phase 2, and IC Biomedical
10-K for FY2025, filed Mar 5, 2026We believe Cryoport is unique in its services and product offerings. Collectively, Cryoport’s specialized expertise in providing advanced…View ↗
Loading...